Tirzepatide access
Wellmedr vs Embody: Which One Offers Tirzepatide? (2026)
Wellmedr $89/mo vs Embody $69/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.4 and 7.6 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Comparing Wellmedr with Embody means comparing two business models more than two medications. The molecules overlap; the terms do not.
Molecule availability is the fork here: Embody covers both semaglutide and tirzepatide, while Wellmedr publishes semaglutide alone. That matters most to anyone who may want to switch rather than simply escalate.
Everything here is drawn from each provider's own published pricing and program detail, then extended into six- and twelve-month totals so the two become comparable. Undisclosed pricing is treated as a finding, not rounded into an estimate.
The short answer
- Lowest 12-month cost
- Embody — $828 against $1,068 at Wellmedr, on each provider's own best published pricing.
- Most predictable bill
- Wellmedr — Price locked for the life of the plan, so titration does not change what you are charged.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Longest public track record
- Embody — 11,250 patient reviews against 4,925.
The short version: Wellmedr vs Embody
Read the second row before the first: the advertised price and the price you actually run at are frequently different numbers.
| Wellmedr | Embody | |
|---|---|---|
| Advertised price | Semaglutide from $89/mo on the 1-year plan | Semaglutide $69/mo (was $299), tirzepatide $119/mo |
| Rate after promotions | $89/mo | $69/mo |
| Pricing structure | Price locked for the life of the plan | Published rate per medication |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | $119/mo |
| Support model | No coaching program stated | No coaching program stated |
| Price transparency | Partly published | Published upfront |
| Payment options | Card only, no financing published | Card only, no financing published |
| Shipping | Free overnight shipping | Free shipping, 1-2 day delivery after approval |
| Patient reviews | 4,925 | 11,250 |
| eRxDoctor score | 9.4/10 | 7.6/10 |
What Wellmedr and Embody actually cost over a year
Almost every complaint about telehealth GLP-1 pricing traces back to comparing month one instead of month twelve. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| Wellmedr | Embody | |
|---|---|---|
| First month | $89 | $69 |
| Months 2 onward | $89/mo | $69/mo |
| 6-month total | $534 | $414 |
| 12-month total | $1,068 | $828 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Embody finishes the year $240 cheaper. For some patients the support Wellmedr bundles closes that gap; for a patient who only needs the prescription written, it does not.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
Embody publishes both, with tirzepatide at $119/mo. Wellmedr publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
Optionality has a price and it is usually small. Weigh it against the cost of restarting the whole process elsewhere in six months.
A closer look at Wellmedr
GLP-1 Plans Starting at Just $89/Month In this pairing, its distinguishing feature is locked-in pricing with no dose-based increases at one of the lowest published rates.
From signup to first shipment: same-day review, then free overnight shipping. Billing follows a price locked for the life of the plan structure.
What continues after the first shipment: same-day clinician review. Formulary: compounded semaglutide.
Wellmedr pros
- No dose-based price increases
- Lifetime locked-in pricing
Wellmedr cons
The cost of choosing this over Embody: the $89 rate is tied to a one-year commitment and the platform publishes little else.
How Embody works
Semaglutide $69/mo (was $299), Tirzepatide $119/mo What it is really selling here is the lowest published semaglutide price on this list, with no lock-in.
Practically: licensed provider review handled entirely online, free shipping, 1-2 day delivery after approval, and a pricing model that is published rate per medication.
On the clinical side, 24/7 support for dosing and side-effect questions, prescribing compounded semaglutide and compounded tirzepatide.
Embody pros
- Licensed provider review handled entirely online
- 24/7 support access for dosing and side-effect questions
- Free shipping with fast 1–2 day delivery after approval
- No long-term commitment; cancel without penalty
Embody cons
- $69 semaglutide pricing is a limited-time offer that may increase
- Final pricing may vary based on dose and clinician recommendation
- Fewer premium features (no integrated coaching or advanced monitoring) than higher-priced platforms
The reservation worth holding, particularly next to Wellmedr: a limited-time rate with few of the extras that higher-priced platforms bundle.
Who should choose Wellmedr, and who should choose Embody
Choose Wellmedr if:
- delivery works the way you want it to: free overnight shipping
- what it leads on is worth paying for in your case: locked-in pricing with no dose-based increases at one of the lowest published rates
- you want the price you sign up at to survive titration
- you want to start on their timeline: same-day review
Choose Embody if:
- the twelve-month total is what you are optimizing ($828 against $1,068)
- you want the full price in front of you before completing an intake
- you want tirzepatide available without changing provider later
- the monthly rate is the constraint — $69/mo against $89/mo
What each one gives up
On price. Embody is the cheaper program at $69/mo against $89/mo. What Embody gives up for that is a limited-time rate with few of the extras that higher-priced platforms bundle; what Wellmedr charges for is locked-in pricing with no dose-based increases at one of the lowest published rates.
On medication. Wellmedr covers compounded semaglutide; Embody covers compounded semaglutide and compounded tirzepatide. Only Embody publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. Wellmedr provides same-day clinician review. Embody provides 24/7 support for dosing and side-effect questions. Both are asynchronous-first services and neither replaces a physician who can examine you.
On predictability. Price locked for the life of the plan at Wellmedr, against published rate per medication at Embody. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
Evidence and regulatory status
The efficacy data people cite when comparing these platforms is not platform data. It comes from trials of the underlying medication, and it applies to both.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Wellmedr vs Embody: common questions
Which is cheaper to start, Wellmedr or Embody?
Embody, at $69 against $89. Note that the cheapest first month and the cheapest year are often different providers here — check the 12-month row of the cost table before deciding on the entry price.
What happens when Embody's promotional price ends?
The rate moves to $69/mo, a 0% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
How fast can I start with Wellmedr compared with Embody?
Wellmedr advertises same-day review, with free overnight shipping. Embody advertises licensed provider review handled entirely online, with free shipping, 1-2 day delivery after approval. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do Wellmedr or Embody take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Which has more patient reviews, Wellmedr or Embody?
Embody, with 11,250 against 4,925. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Does Wellmedr or Embody offer tirzepatide?
Embody does, at $119/mo. Wellmedr publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
Do Wellmedr and Embody prescribe the same medication?
Both dispense compounded GLP-1 preparations. Wellmedr lists compounded semaglutide and Embody lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
The verdict
Embody is the cheaper year by $240, and for a straightforward course of treatment that settles it.
Where Wellmedr justifies itself is locked-in pricing with no dose-based increases at one of the lowest published rates. Where it does not is anywhere the extra spend buys features you will never open.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Wellmedr vs NoviTirzepatide access
- Wellmedr vs TMatesBudget vs premium
- Embody vs WellorithmPublished price vs quote-only
- Embody vs Ro.coBrand-name vs compounded
- Novi vs TMatesTirzepatide access
- Mochi Health vs Elevate HealthTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Wellmedr or Embody, and does not sell treatment. Read our ranking methodology.